Orser Capital Management LLC Invests $849,000 in Intuitive Surgical, Inc. $ISRG

Orser Capital Management LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 2,135 shares of the medical equipment provider’s stock, valued at approximately $849,000.

Several other institutional investors and hedge funds also recently made changes to their positions in ISRG. Norges Bank bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $2,856,987,000. J. Stern & Co. LLP boosted its holdings in shares of Intuitive Surgical by 18,504.6% during the 4th quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock worth $1,204,788,000 after buying an additional 2,115,814 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Intuitive Surgical by 1,043.3% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock worth $760,124,000 after buying an additional 1,224,734 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its position in shares of Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock worth $970,635,000 after buying an additional 1,027,475 shares during the period. Finally, Polen Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter worth approximately $477,225,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of Intuitive Surgical stock in a transaction dated Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the transaction, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. The trade was a 6.54% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 6,634 shares of company stock valued at $2,796,795. 0.60% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research report on Tuesday, May 19th. Royal Bank Of Canada reduced their price target on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, July 13th. The Goldman Sachs Group set a $558.00 price target on shares of Intuitive Surgical in a research note on Wednesday, May 27th. Evercore set a $430.00 price objective on shares of Intuitive Surgical in a report on Monday, July 6th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating on the stock in a research report on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $509.02.

Intuitive Surgical Trading Down 0.4%

NASDAQ ISRG opened at $373.71 on Friday. The company has a market cap of $132.02 billion, a P/E ratio of 42.81, a PEG ratio of 2.71 and a beta of 1.46. The company has a fifty day simple moving average of $393.78 and a 200 day simple moving average of $446.25. Intuitive Surgical, Inc. has a 12-month low of $328.57 and a 12-month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a net margin of 28.45% and a return on equity of 16.91%. The firm had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the prior year, the company posted $1.81 earnings per share. The business’s revenue was up 18.4% on a year-over-year basis. Sell-side analysts predict that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.